Saira Ramasastry, Director at Mirum Pharmaceuticals, Inc. (MIRM), sold 13,906 shares at $46.20 ($641K) on 2025-06-02, disclosed to the SEC on 2025-06-04.
Open-market sale of $641k MIRM by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $46.20 | 5,703 | $263K | 41.1% |
| 2 | $46.20 | 5,703 | $263K | 41.1% |
| 3 | $45.74 | 2,500 | $114K | 17.8% |
| Total | $46.12 avg | 13,906 | $641K | 100% |
| Filing → |
| MIRM | SELL | 2026-04-16 | $194K | — | Filing → |
| MIRM | SELL | 2026-03-17 | $182K | — | Filing → |
| MIRM | SELL | 2026-02-17 | $204K | — | Filing → |